These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37784135)

  • 1. CYP19A1 promotes gastric cancer as part of a lipid metabolism-related gene signature related to the response of immunotherapy and prognosis.
    Zhou X; Meng F; Xiao L; Shen H
    BMC Med Genomics; 2023 Oct; 16(1):228. PubMed ID: 37784135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting inhibition of prognosis-related lipid metabolism genes including CYP19A1 enhances immunotherapeutic response in colon cancer.
    Liu L; Mo M; Chen X; Chao D; Zhang Y; Chen X; Wang Y; Zhang N; He N; Yuan X; Chen H; Yang J
    J Exp Clin Cancer Res; 2023 Apr; 42(1):85. PubMed ID: 37055842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunogenic cell death-related signature predicts prognosis and immunotherapy response in stomach adenocarcinoma.
    Liu Z; Sun L; Peng X; Liu S; Zhu Z; Huang C
    Apoptosis; 2023 Dec; 28(11-12):1564-1583. PubMed ID: 37580435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid Metabolic-Related Signature CYP19A1 is a Potential Biomarker for Prognosis and Immune Cell Infiltration in Gastric Cancer.
    Wang N; Huang X; Long Q
    J Inflamm Res; 2022; 15():5075-5088. PubMed ID: 36091333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microenvironment characteristics of lipid metabolism reprogramming related to ferroptosis and EndMT influencing prognosis in gastric cancer.
    Zhao Q; Yu H; Shi M; Wang X; Fan Z; Wang Z
    Int Immunopharmacol; 2024 Aug; 137():112433. PubMed ID: 38870879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic and immune-related gene signatures: Predictive stratification and prognostic implications in gastric cancer.
    Shao J; Zhang W; Li Y; Tang Y; Fan L
    J Gene Med; 2024 Jan; 26(1):e3635. PubMed ID: 37984993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation analysis of lipid metabolism genes with the immune microenvironment in gastric cancer and the construction of a novel gene signature.
    Li Y; Chen X; Zhang R; Chen M; Shen J; Wu J; Yu J; Sun Q
    Clin Transl Oncol; 2023 May; 25(5):1315-1331. PubMed ID: 36520384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma.
    Zhou R; Peng N; Li W
    Front Immunol; 2022; 13():964919. PubMed ID: 36059494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
    Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning reveals two heterogeneous subtypes to assist immune therapy based on lipid metabolism in lung adenocarcinoma.
    Gu X; Wei S; Li Z; Xu H
    Front Immunol; 2022; 13():1022149. PubMed ID: 36238302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of nucleotide metabolism and neuroendocrine regulation-associated modification patterns in stomach adenocarcinoma with auxiliary prognostic assessment and immunotherapy response prediction.
    Zhang Y; Zeng L; Lin D; Chang G; Zeng Y; Xia Y
    Front Endocrinol (Lausanne); 2022; 13():1076521. PubMed ID: 36726460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty acid metabolism is related to the immune microenvironment changes of gastric cancer and RGS2 is a new tumor biomarker.
    Yang S; Sun B; Li W; Yang H; Li N; Zhang X
    Front Immunol; 2022; 13():1065927. PubMed ID: 36591293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressions of the correlation between lipid metabolism and immune infiltration characteristics in gastric cancer and identification of BCHE as a potential biomarker.
    Wang S; Huang X; Zhao S; Lv J; Li Y; Wang S; Guo J; Wang Y; Wang R; Zhang M; Qiu W
    Front Immunol; 2024; 15():1327565. PubMed ID: 38357546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of three immune subtypes characterized by distinct tumor immune microenvironment and therapeutic response in stomach adenocarcinoma.
    Zhu Y; Zhao Y; Cao Z; Chen Z; Pan W
    Gene; 2022 Apr; 818():146177. PubMed ID: 35065254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling.
    Liu C; Tao Y; Lin H; Lou X; Wu S; Chen L
    Front Mol Biosci; 2022; 9():962435. PubMed ID: 36090054
    [No Abstract]   [Full Text] [Related]  

  • 17. A novel prognostic index of stomach adenocarcinoma based on immunogenomic landscape analysis and immunotherapy options.
    Xue W; Dong B; Wang Y; Xie Y; Li P; Gong Z; Niu Z
    Exp Mol Pathol; 2022 Oct; 128():104832. PubMed ID: 36122795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature.
    Zhang S; Lv M; Cheng Y; Wang S; Li C; Qu X
    BMC Cancer; 2021 Dec; 21(1):1324. PubMed ID: 34893046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of prognosis and immunometabolism landscapes in ER+ breast cancer based on a novel lipid metabolism-related signature.
    Shen L; Huang H; Li J; Chen W; Yao Y; Hu J; Zhou J; Huang F; Ni C
    Front Immunol; 2023; 14():1199465. PubMed ID: 37469520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.